Celldex has fallen sharply from multi-year highs reached last month, but one trader believes that any further losses will be limited for the biopharmaceutical company.
More than 6,200 February 4 puts traded in a strong selling pattern for $0.15 and $0.20, according to optionMONSTER's tracking systems. Open interest in the strike was just 121 contracts at the start of the session, so these are new positions.
The put sellers are looking for CLDX to be above the $4 strike price at expiration in mid-February. Below that level, the traders are on the hook to buy the shares. (See our Education section)
CLDX is down 3.14 percent to $5.24 after breaking below its 100-day moving average yesterday. The stock hit $6.71 on Oct. 5, its highest intraday price since June 2010, but is now testing recent support levels.
Options Trading News
Related Stories
CLDX
Trade bets Celldex will hold big gains
June 10, 2013
The biopharmaceutical company has climbed to all-time highs, and one trader apparently believes that the stock will hold its gains.
Social Media
Follow optionMONSTER for news and updates
Premium Services
-
Semi-active traders looking for simple calls and spreads (5 per week).
Learn More -
Entry-to-mid level traders looking for full circle trade analysis (1 per week).
Learn More -
Tailored, one-on-one education designed and led by Jon & Pete (3 months and up)
Learn More
Free Webinars
View archived webinars »Education & Strategy
Why education is key to options
People get into option trading for a number of reasons, but there are three primary motivations: to increase income, to...
